United States · FDA National Drug Code directory
Solifenacin Succinate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0517_4ad0176d-0102-457a-9fcb-472dcedd9709
- Product NDC
- 67184-0517
- Form
- TABLET, FILM COATED
- Composition / generic term
- Solifenacin Succinate Tablets
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200401
- Source listing expiry
- 20261231
Source-listed ingredients
- SOLIFENACIN SUCCINATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (67184-0517-1) · 67184-0517-1
- 90 TABLET, FILM COATED in 1 BOTTLE (67184-0517-2) · 67184-0517-2
- 2000 TABLET, FILM COATED in 1 BOTTLE (67184-0517-3) · 67184-0517-3
- 40 TABLET, FILM COATED in 1 BLISTER PACK (67184-0517-4) · 67184-0517-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →